B2B SaaS Provider · B2C Consumer App / Platform

DOMI

Doctolib vs Mindbody

Structured technology and market comparison · 2026

Direct Feature Comparison

Doctolib · vs · Mindbody
Market Cluster / Sector
DoctolibB2B SaaS Provider · B2C Consumer App / Platform
MindbodyB2B SaaS Provider · B2C Consumer App / Platform
Platform Focus
Doctolib

Healthcare booking and practice software platform for providers and patients.

Mindbody

Wellness business software for scheduling, payments and customer engagement.

Company Size
Doctolib1,001–5,000 employees
Mindbody1,001–5,000 employees
Headquarters
DoctolibFR
MindbodyUS
Year Founded
Doctolib2013
Mindbody2001

Analyze all overlapping signals and tech stacks for Doctolib and Mindbody

Compare mutual enterprise clients, monetization models, live market signals, and partner networks directly in the interactive Knowledge Graph.

Compare free in ExplorerFree · No credit card · 1-click via Google/LinkedIn

Comparison Analysis

What is the main difference between Doctolib and Mindbody?

When comparing Doctolib and Mindbody, both platforms operate within the Marketing Automation Platform, In-App, and B2B SaaS Provider ecosystem. Doctolib is positioned as Healthcare booking and practice software platform for providers and patients, whereas Mindbody focuses on Wellness business software for scheduling, payments and customer engagement. Decision-makers evaluate both solutions when orchestrating their commercial monetization and technology stack.

What are the top alternatives to Doctolib and Mindbody?

When evaluating Doctolib and Mindbody, enterprise buyers also consider other platforms in Marketing Automation Platform, In-App, and B2B SaaS Provider. You can discover the full competitive landscape and evaluate other alternatives by viewing their respective footprint profiles on Polaris7.

How do the corporate scale, structure, and headquarters of Doctolib and Mindbody compare?

Doctolib is headquartered in FR (founded in 2013) with 1,001–5,000 employees. Mindbody is based in US (founded in 2001) with 1,001–5,000 employees. Complete ownership, subsidiary trees, and corporate affiliations are documented across Polaris7.

Market Signals

Recent Market Signals & Activity: Doctolib vs Mindbody

Documented market movements, strategic partnerships, product releases, and regulatory developments mapped across Polaris7.

DO

Doctolib

Recent Signals

  • ·Trending Topics (DACH/CEE Innovation & Tech)AI Investment

    Nvidia invests in Doctolib, Pigment, Genesis AI, Entalpic

    European tech startups raised €15.8 billion in September, nearly five times August's €3.2 billion, with the UK attracting the largest share (46%). Mega-deals included Mistral's €3 billion Series D and Nscale's $3.36 billion convertible notes; even excluding these, funding tripled month-over-month. Nvidia continued its European expansion by announcing minority investments in four French startups (Doctolib, Genesis AI, Pigment, Entalpic) and five UK startups (Boltz, Foresight, Hiverge, Prima Mente, Riverlane), as part of nearly €9 billion in European commitments. CEO Jensen Huang also announced a $250 million compute donation to UK AI safety and research. Critics question circular financing, while Huang advocates continued dialogue with Chinese AI firms. These moves follow Nvidia's recent agreement to acquire Hugging Face for about $12.9 billion.

    • European startups raised €15.8 billion in September, nearly five times August's €3.2 billion.
    • Nvidia announced minority investments in four French (Doctolib, Genesis AI, Pigment, Entalpic) and five UK (Boltz, Foresight, Hiverge, Prima Mente, Riverlane) startups, with total European commitment near €9 billion.
    • Mistral raised €3 billion in Series D at a valuation over €21 billion, the largest equity round for a European tech company.
  • ·Trending Topics (DACH/CEE Innovation & Tech)AI

    Nvidia Invests in Four French Tech Companies

    Nvidia has announced investments in four French technology companies during Jensen Huang's visit to Paris. The companies are Doctolib, a healthcare appointment platform; Genesis AI, a robotics startup; Pigment, a financial planning software maker; and Entalpic, a materials research startup. The deals are minority stakes, but the specific amounts and equity sizes were not disclosed. Nvidia's investment in Doctolib is intended to support its development of AI agents and a digital health companion. This move is part of Nvidia's broader commitment of nearly $10 billion to Europe's tech ecosystem, with plans to announce an additional $2 billion in European deals within a week. The investments have drawn criticism over potential circular financing, where AI firms use the funds to buy Nvidia chips, but Huang rejects these claims.

    • Nvidia invests in Doctolib, Genesis AI, Pigment, and Entalpic.
    • The investments are minority stakes; amounts undisclosed.
    • Investment in Doctolib supports its AI agent and health companion work.
MI

Mindbody

Recent Signals

Compare their exact ecosystem overlaps.

Explore all deep relationships in Polaris7. Discover exactly which mutual clients, integrated technologies, and overlapping partners Doctolib and Mindbody share across the market ecosystem.